Dosage Forms

In this episode, we?ll discuss how an aging global population and the need for continual innovation in the pharmaceutical industry factor into drug delivery systems that move beyond traditional pills and capsules into transdermal drug delivery.

Pliva?s new Oral Solid Forms Facility will increase Pliva's production capacities for tablets and capsules.

Capsule design was developed for patients who have difficulty swallowing.

Interview of Detlev Haack, head of R&D, Hermes Pharma on the characteristics, benefits and manufacturing Methods of effervescent tablets

Stephen Tindal, Director Softgel Formulation at Catalent, talks with Pharm Tech about manufacturing issues with soft gels.

Kansas State University to build Bulk Solids Innovation Center in Salina, Kansas.

Governor Jerry Brown cites physician notification requirements for dispensing biosimilars as premature in the absence of FDA specifications for interchangeability.

Scientific Digital Imaging's Synbiosis Division introduces SynStats statistical analysis software.

HERMES PHARMA has pioneered user-friendly dosage forms. Our effervescent and chewable tablets, lozenges, orally disintegrating granules and instant drinks are convenient to use, easy to swallow and taste good.

Aesica expands aseptic capabilities at its Nottingham, UK site with the acquisition of new pre-filled syringes manufacturing equipment.

Pfenex modifies its contract with US government for Anthrax vaccine.

3M Drug Delivery will manufacture transdermal patch for ProStrakan.

Advanced Biosciences Laboratories will support the development and production of a novel Shigella vaccine candidate for PATH.

Industry experts discuss the importance of characterization studies during biosimilars development and related analytical methods.

Analytical methods are being used to troubleshoot tablet-sticking problems and to develop screening methods and predictive models to more quickly find solutions.

An industry leader since 1933, Catalent develops and manufactures over 80% of the world's Rx softgel products with 200+ products on the market in 80+ countries.

Boehringer Ingelheim initiates a recall due to the potential for extrinsic foreign particles in the API used to manufacture Spiriva Handihaler (tiotropium bromide inhalation powder) capsules.

Pfizer advances its pipeline of antibody-based therapies using a host cell line that combines engineered glycosylation technology and enhanced gene-expression.

Hospira's Inflectra (infliximab), which is a biosimilar to the reference biologic product, Remicade, has been approved by the EC for the treatment of inflammatory conditions.

Foam granulation is much easier to control under mechanical dispersion conditions, which is where most industrial processes operate.

Novartis? half-billion dollar investment in a new biologics production plant in Singapore represents a strategic commitment to its growing biologics portfolio.

Mylan completes expansion of its transdermal patch facility in Vermont.

Sanofi and POZEN sign a license agreement for the commercialization of omeprazole and aspirin combination product.

Following passage in the California Assembly, the California State Senate passes legislation to specify requirements for dispensing biosimilars.

Merck & Co gets FDA approval to manufacture bulk varicella at its in Durham, North Carolina for use in chickenpox and shingles vaccines.

Baxter and Coherus Biosciences colaborate to develop and commercialize a biosimilar version of etanercept for Europe, Canada, and, Brazil.

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

Prequalification of Sanofi Pasteur?s Menomune vaccine makes it eligible for purchase by United Nations agencies.

Avacta?s Optim 2 instrument provides a practical solution for determining the conformational stability of adjuvant bound vaccines, eliminating the need for awkward and time consuming standard analytical techniques. [more?..]

The advantages of using an automated powder dispensing system in a ventilated balance enclosure for efficient handling and effective containment of potent compounds are discussed.